Novavax(CH:NVAX)
CH:NVAX
Novavax earnings date
Novavax (NVAX) Q2 2026 Earnings Report
2 Followers
CH:NVAX Q2 2026 EPS Results
- Actual EPS
- -CHF 0.26
- Consensus EPS
- -CHF 0.31
- Beat/Miss
- Beat by +CHF 0.05
- One Year Ago EPS
- CHF 0.51
CH:NVAX Q2 2026 Revenue Results
- Actual Revenue
- CHF 46.80M
- Expected Revenue
- CHF 43.34M
- Beat/Miss
- Beat by +CHF 3.46M
- YoY Revenue Growth
- -76.30%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
CH:NVAX Upcoming Earnings
Novavax's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:NVAX Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NVAX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.45- | 0.09 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.29-0.16 | -1.03 | 84.80% (+0.87) | |
| Aug 06, 2026 | 2026 (Q2) | -0.31-0.26 | 0.51 | -151.61% (-0.78) | |
| May 06, 2026 | 2026 (Q1) | -0.20-0.05 | 2.42 | -102.05% (-2.47) | |
| Feb 26, 2026 | 2025 (Q4) | -0.400.09 | -0.42 | 121.57% (+0.51) | |
| Nov 06, 2025 | 2025 (Q3) | -0.99-1.03 | -0.63 | -64.47% (-0.40) | |
| Aug 06, 2025 | 2025 (Q2) | 0.010.51 | 0.82 | -37.37% (-0.31) | |
| May 08, 2025 | 2025 (Q1) | -0.352.42 | -0.87 | 379.05% (+3.29) | |
| Feb 27, 2025 | 2024 (Q4) | -0.42-0.42 | -1.19 | 64.58% (+0.77) | |
| Nov 12, 2024 | 2024 (Q3) | -0.65-0.63 | -1.04 | 39.68% (+0.41) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


